NurOwn is the clearest test yet of how far the agency may be willing to bend to approve a new medicine for a rare and deadly condition with few treatment options.
The meeting was scheduled after ALS advocates delivered a 30,000-signature petition seeking a public vetting of the treatment. “The amazing testimonials we have seen online do not align with the data that Brainstorm has shared,” the group said in a statement. NurOwn is made from stem cells collected from patients’ bone marrow. The cells are processed in a lab with biological proteins designed to promote nerve growth, and then injected into the spinal column.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: DenverChannel - 🏆 239. / 63 Read more »
Source: MarketWatch - 🏆 3. / 97 Read more »
Source: ABC7Chicago - 🏆 284. / 63 Read more »